This important cross-species study tests whether the corpus callosum contains parallel, segregated pathways for ipsilateral and contralateral visual-field information, rather than mixed inputs from ...

Abstract: Cepstral features, such as Gammatone Cepstral Coefficients (GTCC), have recently been applied in fault detection and diagnosis. However, GTCC was originally designed for speech feature ...

Diffusion policy exhibits promising multimodal property and distributional expressivity in robotic field, while not ready for real-time end-to-end autonomous driving in more dynamic and open-world ...

The dorsal S-duct inlet of a HALE blended wing body UAV faces complex unsteady disturbances during operation. This study ...

Glioblastoma, the most aggressive malignant brain tumor in adults, is not an isolated lesion, but a disease that destabilizes ...

Abstract: Diffusion models have recently gained significant attention in both academia and industry due to their impressive generative performance in terms of both sampling quality and distribution ...

Antimony sulfide (Sb2S3) is a competitive photovoltaic material, especially for tandem solar cells. However, the ...

AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI biotech startup Coefficient Bio in a $400 million stock deal, according to ...

Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations. AI leader Anthropic ...

Anthropic is making strides in the AI space. The AI firm has acquired stealth startup Coefficient Bio for over $400 million in an all-stock deal. Closed in early April 2026, the acquisition pulls a ...

Anthropic (ANTHRO) has acquired Coefficient Bio, a biotech focused on developing AI models for biological research, for slightly more than $400M, according to The Information and a report from Eric ...

Anthropic PBC has reportedly acquired Coefficient Bio Inc., a provider of artificial intelligence software for medical researchers. Half the startup’s stock was owned by a healthcare-focused venture ...